Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API


logo
Atara Biotherapeutics logo

Atara Biotherapeutics

Recent Finacing

Series B

Recent Raise

$38.5M

Atara Biotherapeutics is a drug-development company creating biologic therapies for nephrology and oncology, advancing PINTA-745 Phase-2 for protein-energy wasting and IND-ready STM-434 for solid tumors.

Founded 2012
California, United States
251-500
Publicly Traded
atarabio.com

Highlights

Focus Areas

Biotechnology
Health Care
Oncology
Therapeutics

Recent Investors

Amgen Ventures logo
Kleiner Perkins logo
Celgene logo
Alexandria Venture Investments logo
Domain Associates logo
EcoR1 Capital logo
DAG Ventures logo

Financials

$38.5M

Total Raised

2

Funding rounds

7

Investors